Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
Journal: Circulation
Published: August 25, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.
Journal: JAMA cardiology
Published: June 17, 2026
Fatal Steam Pop Complicating Investigational SESAME Transcatheter Myotomy Using Off-the-Shelf Equipment.
Journal: Circulation. Cardiovascular interventions
Published: January 26, 2026
Mavacamten Monotherapy in Real-World Patients With Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCM.
Journal: Circulation. Genomic and precision medicine
Published: November 10, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Journal: Journal of cardiac failure
Published: October 16, 2025
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy.
Journal: Journal of the American College of Cardiology
Published: October 11, 2025
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial.
Journal: Journal of the American College of Cardiology
Published: October 11, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: September 01, 2025
Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM.
Journal: Journal of the American College of Cardiology
Published: July 24, 2025
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Journal: JACC. Heart failure
Published: February 25, 2025
Last Updated: 09/26/2026